Canadian Investment Regulatory Organization Trade Resumption - CRDL

Canadian Investment Regulatory Organization Trade Resumption - CRDL

Trading resumes in:

Company: Cardiol Therapeutics Inc.

TSX Symbol: CRDL

All Issues: Yes

Resumption (ET): 8:00 AM

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada..

SOURCE Canadian Investment Regulatory Organization (CIRO) – Halts/Resumptions

Cision View original content: http://www.newswire.ca/en/releases/archive/October2025/20/c1710.html

News Provided by Canada Newswire via QuoteMedia

crdl:catsx:crdlbiotech investing
CRDL:CA
The Conversation (0)
BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

Other recently activated sites include Indiana University Melvin and Bren Simon Comprehensive Cancer Center, University of Virginia (UVA) Comprehensive Cancer Center, Baptist Health South Florida, and SCRI Oncology Partners briacell therapeutics corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) ("BriaCell"... Keep Reading...
Glowing DNA strand against blue background with digital graphs and glowing bars.

Hantavirus Outbreak Sparks Rollercoaster Ride for Biotech Stocks

A localized hantavirus outbreak aboard an Atlantic cruise ship triggered a brief, speculative frenzy in biotechnology stocks this week.Shares of prominent vaccine developers fluctuated on Monday (May 11) as retail investors attempted to front run what they perceived as a burgeoning global health... Keep Reading...
BriaCell Phase 3 Bria-IMT Study Enrollment Surpasses 230 Patients

BriaCell Phase 3 Bria-IMT Study Enrollment Surpasses 230 Patients

Over 315 patients screened and over 230 patients enrolled in BriaCell's pivotal Phase 3 Bria-ABC study of Bria-IMT plus immune checkpoint inhibitor in metastatic breast cancer Enrollment momentum continues with strong clinical site and patient interestInterim topline data expected in... Keep Reading...
BriaCell Therapeutics (TSX:BCT)

BriaCell Therapeutics: Redefining Oncology with Personalized Cancer Immunotherapy

Keep Reading...
BriaCell Therapeutics (TSX:BCT)

BriaCell Therapeutics

Keep Reading...
Lexaria Bioscience Releases Second Episode of Investor Video Series

Lexaria Bioscience Releases Second Episode of Investor Video Series

CEO Rich Christopher Discusses Recently Announced Material Transfer Agreement Extension and 2026 Research Priorities KELOWNA, BC / ACCESS Newswire / May 7, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in oral drug delivery platforms, today... Keep Reading...

Latest News

Interactive Chart

Latest Press Releases

Valeura Energy Inc Announces First Quarter 2026 Results

MAYFAIR GOLD REPORTS Q1 2026 OPERATING AND FINANCIAL RESULTS

Trading Halt

Supplementary Prospectus

Related News

oil and gas investing

Valeura Energy Inc Announces First Quarter 2026 Results

precious metals investing

MAYFAIR GOLD REPORTS Q1 2026 OPERATING AND FINANCIAL RESULTS

base metals investing

Trading Halt

precious metals investing

Supplementary Prospectus

precious metals investing

Boundiali 3.22 Moz gold - Indicated up 24% to 1.70 Moz

gold investing

Clem Chambers: Gold is for War — But That's Not What I'm Buying Now

cobalt investing

Supra Elemental Targeting Critical Minerals Gap with Recovery Tech